enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
0.3402
+0.0062 (1.86%)
Jan 14, 2026, 1:31 PM EST - Market open
enVVeno Medical Market Cap
enVVeno Medical has a market cap or net worth of $6.88 million as of January 14, 2026. Its market cap has decreased by -87.18% in one year.
Market Cap
6.88M
Enterprise Value
-23.41M
1-Year Change
-87.18%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since May 31, 2018, enVVeno Medical's market cap has decreased from $40.00M to $6.88M, a decrease of -82.81%. That is a compound annual growth rate of -20.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 6.75M | 4.11% |
| Dec 31, 2025 | 6.49M | -87.75% |
| Dec 31, 2024 | 52.96M | -22.63% |
| Dec 29, 2023 | 68.45M | 41.69% |
| Dec 30, 2022 | 48.31M | -22.58% |
| Dec 31, 2021 | 62.40M | 222.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 955.77B |
| Johnson & Johnson | 498.80B |
| AbbVie | 390.63B |
| UnitedHealth Group | 305.06B |
| AstraZeneca | 295.57B |
| Novartis AG | 272.98B |
| Merck & Co. | 271.58B |
| Novo Nordisk | 263.81B |